Age-dependent gene expression profile and protein expression in atransgenic rat model of Huntington's disease

Proteomics - Clinical Applications

Volumn 2, Issue 12, 2008, Pages 1638-1650

  Nguyen, Huu Phuc ^a   Metzger, Silke ^a   Holzmann, Carsten ^b   Koczan, Dirk ^b   Thiesen, Hans Jürgen ^b   von Hörsten, Stephan ^c   Riess, Olaf ^a   Bonin, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Huntingtin; Protein expression; Time course; Transcriptome; Transgenic rat

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR 1; 4 AMINOBUTYRIC ACID B RECEPTOR 2; TRANSCRIPTION FACTOR JUND; TRANSCRIPTOME; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM SIGNALING; CELL COMMUNICATION; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION PROFILING; GENE MUTATION; GENE SEQUENCE; HUNTINGTON CHOREA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEQUENCE ANALYSIS; TRANSGENIC RAT; TRINUCLEOTIDE REPEAT; WESTERN BLOTTING;

RATTUS;

EID: 58449127187     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800018     Document Type: Article

References (35)

1. The Huntington's Disease Collaborative Research Group, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72, 971-983.
2. Sugars, K. L.,Rubinsztein, D. C., Transcriptional abnormalities in Huntington disease. Trends Genet. 2003, 19, 233-238.
3. Steffan, J. S., Bodai, L., Pallos, J., Poelman, M. et al., Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 2001, 413, 739-743.
4. Hockly, E., Richon, V. M., Woodman, B., Smith, D. L. et al., Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. USA 2003, 100, 2041-2046.
5. Chan, E. Y., Luthi-Carter, R., Strand, A., Solano, S. M. et al., Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease. Hum. Mol. Genet. 2002, 11, 1939-1951.
6. Desplats, P. A., Kass, K. E., Gilmartin, T., Stanwood, G. D. et al., Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease. J. Neurochem. 2006, 96, 743-757.
7. Hodges, A., Strand, A. D., Aragaki, A. K., Kuhn, A. et al., Regional and cellular gene expression changes in human Huntington's disease brain. Hum. Mol. Genet. 2006, 15, 965-977.
8. Kuhn, A., Goldstein, D. R., Hodges, A., Strand, A. D. et al., Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum. Mol. Genet. 2007, 16, 1845-1861.
9. Luthi-Carter, R., Hanson, S. A., Strand, A. D., Bergstrom, D. A. et al., Dysregulation of gene expression in the R6/2 model of polyglutamine disease: Parallel changes in muscle and brain. Hum. Mol. Genet. 2002, 11, 1911-1926.
10. Luthi-Carter, R., Strand, A., Peters, N. L., Solano, S. M. et al., Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet. 2000, 9, 1259-1271.
11. Luthi-Carter, R., Strand, A. D., Hanson, S. A., Kooperberg, C. et al., Polyglutamine and transcription: Gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects. Hum. Mol. Genet. 2002, 11, 1927-1937.
12. Sipione, S., Rigamonti, D., Valenza, M., Zuccato, C. et al., Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses. Hum. Mol. Genet. 2002, 11, 1953-1965.
13. Nguyen, H. P., Kobbe, P., Rahne, H., Worpel, T. et al., Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. Hum. Mol. Genet. 2006, 15, 3177-3194.
14. von Horsten, S., Schmitt, I., Nguyen, H. P., Holzmann, C. et al., Transgenic rat model of Huntington's disease. Hum. Mol. Genet. 2003, 12, 617-624.
15. Kantor, O., Temel, Y., Holzmann, C., Raber, K. et al., Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats. Neurobiol. Dis. 2006, 22, 538-547.
16. Fan, M. M., Raymond, L. A., N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Prog. Neurobiol. 2007, 81, 272-293.
17. Young, A. B., Greenamyre, J. T., Hollingsworth, Z., Albin, R. et al., NMDA receptor losses in putamen from patients with Huntington's disease. Science 1988, 241, 981-983.
18. Freese, A., DiFiglia, M., Koroshetz, W. J., Beal, M. F., Martin, J. B., Characterization and mechanism of glutamate neurotoxicity in primary striatal cultures. Brain Res. 1990, 521, 254-264.
19. Arning, L., Kraus, P. H., Valentin, S., Saft, C. et al., NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. Neurogenetics 2005, 6, 25-28.
20. Kalchman, M. A., Koide, H. B., McCutcheon, K., Graham, R. K. et al., HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nat. Genet. 1997, 16, 44-53.
21. Wanker, E. E., Rovira, C., Scherzinger, E., Hasenbank, R. et al., HIP-I: A huntingtin interacting protein isolated by the yeast two-hybrid system. Hum. Mol. Genet. 1997, 6, 487-495.
22. Modregger, J., DiProspero, N. A., Charles, V., Tagle, D. A., Plomann, M., PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains. Hum. Mol. Genet. 2002, 11, 2547-2558.
23. Cha, J. H., Transcriptional dysregulation in Huntington's disease. Trends Neurosci. 2000, 23, 387-392.
24. Cha, J. H., Transcriptional signatures in Huntington's disease. Prog. Neurobiol. 2007, 83, 228-248.
25. Dunah, A.W., Jeong, H., Griffin, A., Kim, Y. M. et al., Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 2002, 296, 2238-2243.
26. Li, S. H., Cheng, A. L., Zhou, H., Lam, S. et al., Interaction of Huntington disease protein with transcriptional activator Sp1. Mol. Cell. Biol. 2002, 22, 1277-1287.
27. Nucifora, F. C., Jr., Sasaki, M., Peters, M. F., Huang, H. et al., Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 2001, 291, 2423-2428.
28. Yu, Z. X., Li, S. H., Nguyen, H. P., Li, X. J., Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice. Hum. Mol. Genet. 2002, 11, 905-914.
29. Luthi-Carter, R., Apostol, B. L., Dunah, A. W., DeJohn, M. M. et al., Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: Analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation. Neurobiol. Dis. 2003, 14, 624-636.
30. Lastres-Becker, I., Berrendero, F., Lucas, J. J., Martin-Aparicio, E. et al., Brain Res. 2002, 929, 236-242
31. Mijalski, T., Harder, A., Halder, T., Kersten, M. et al., Identification of coexpressed gene clusters in a comparative analysis of transcriptome and proteome in mouse tissues. Proc. Natl. Acad. Sci. USA 2005, 102, 8621-8626.
32. Zheng, P. Z., Wang, K. K., Zhang, Q. Y., Huang, Q. H. et al., Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 2005, 102, 7653-7658.
33. Frey, I. M., Rubio-Aliaga, I., Siewert, A., Sailer, D. et al., Profiling at mRNA, protein, and metabolite levels reveals alterations in renal amino acid handling and glutathione metabolism in kidney tissue of Pept2-/- mice. Physiol. Genomics 2007, 28, 301-310.
34. Borovecki, F., Lovrecic, L., Zhou, J., Jeong, H. et al., Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc. Natl. Acad. Sci. USA 2005, 102, 11023-11028.
35. Runne, H., Kuhn, A., Wild, E. J., Pratyaksha, W. et al., Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood. Proc. Natl. Acad. Sci. USA 2007, 104, 14424-14429.